Restructuring Charges

3 Months Ended

Mar. 31, 2022

Restructuring Charges [Abstract]

Restructuring Charges

13.   Restructuring Charges On March 31, 2022, the Company initiated a plan to reduce its operating expenses, preserve financial resources, and focus its sales and marketing efforts on increasing utilization of CellFX Systems. The Company’s Board of Directors has approved changes to the Company’s commercial leadership, restructuring of its commercial field organization and reductions in other personnel and expenses across the Company. The Company announced a reduction in force effective as of March 31, 2022. The affected employees were offered separation benefits, including severance payments along with temporary healthcare coverage assistance. The Company has accrued a discrete restructuring related charge of $0.7 million on the condensed consolidated balance sheet as of March 31, 2022 and the related expenses are included within total cost and expenses on the condensed consolidated statement of operations for the three-month period ended March 31, 2022. This charge represents the total expected amount to be incurred in connection with the activity. The balance of $0.7 million is expected to be paid throughout 2022.